People

Chuck Cleland
Charles M. Cleland, PhD
CDUHR - Co-Director, Transdisciplinary Research Methods Core
NYU Langone Health - Associate Professor, Department of Population Health
Education
PhD, Psychology, New School for Social Research
MA, Psychology, New School for Social Research
BA, Psychology, Hampden-Sydney College

Research Interests
HIV prevention, Health disparities, Substance use, Sexual health, Longitudinal data analysis
BIO
Charles Cleland is a quantitative psychologist and biostatistician with more than ten years of experience in the field of public health research. His methodological interests include longitudinal data analysis, meta­-analysis, respondent­ driven sampling, and multilevel modeling. His substantive research interests include health disparities, particularly in the areas of substance use and infectious disease.
Publications

Recent

Frank D, Bennett AS, Elliott L, Scheidell JD, Walters SM, Cleland CM (2025).
An examination of how people who use drugs conceptualize the benefits and drawbacks of using overdose prevention centers
Contemporary Drug Problems, 52 (4), 584-597. doi: 10.1177/00914509251346135.

Wilton L, Gwadz M, Cleland CM, Munson MR, Campos S, Israel K, Medvedchikova M, Beharie N, Rosmarin-DeStefano C, Sherpa D, Serrano S (2025).
Social processes and engagement along the HIV care continuum: A mixed methods exploratory study with diverse African American/Black and Latine emerging adults living with HIV
International Journal for Equity in Health, 24 (1), 295. doi: 10.1186/s12939-025-02662-5. PMCID: PMC12560509.

Cluesman SR, Gwadz M, Cleland CM (2025).
PrEP intentions, heavy substance use, and gender affirmation among Black and Latine transgender and gender-expansive youth: A structural equation modeling analysis
AIDS and Behavior [Epub 2025 Oct 10]. doi: 10.1007/s10461-025-04897-3.

Choi S, Hong S, Fawole A, Heck A, Lincourt P, Jordan AE, Hussain S, O'Grady MA, Bao Y, Cleland CM, Adhikari S, Cerda M, Krawczyk N, Kyanko K, McNeely J, Cunningham C, Mijanovich T, Howland R, Thornburg O, Hutchinson M, Liebmann E, Neighbors CJ (2025).
Advancing person-centered care: Protocol for quality measurement and management (QM2) in the New York State system for opioid use disorder treatment
PLoS One, 20 (9), e0330882. doi: 10.1371/journal.pone.0330882. PMCID: PMC12478935.

Gwadz M, Robinson JA, Serrano FGB, Campos S, Freeman RM, Chero R, Cleland CM, Parameswaran L, Hawkins RL, Filippone P, Lizardo M, Bangser G, Ramirez PG, Negret A, Kagzi M, Lissinna H (2025).
Perspectives on COVID-19 vaccination among unvaccinated and under-vaccinated African American/Black and Latine frontline essential workers: A qualitative exploration
AIDS and Behavior, 29 (8), 2461-2482. doi: 10.1007/s10461-025-04708-9. PMCID: PMC12228974.


Notable

Kurth AE, Spielberg F, Cleland CM, Lambdin B, Bangsberg DR, Frick PA, Severynen AO, Clausen M, Norman RG, Lockhart D, Simoni JM, Holmes KK (2014).
Computerized counseling reduces HIV-1 viral load and sexual transmission risk: Findings from a randomized controlled trial
Journal of Acquired Immune Deficiency Syndromes, 65 (5), 611-620. doi: 10.1097/QAI.0000000000000100. PMCID: PMC3999203.

Marsch LA, Guarino H, Acosta M, Aponte-Melendez Y, Cleland C, Grabinski M, Brady R, Edwards J (2014).
Web-based behavioral treatment for substance use disorders as a partial replacement of standard methadone maintenance treatment
Journal of Substance Abuse Treatment, 46 (1), 43-51. doi: 10.1016/j.jsat.2013.08.012. PMCID: PMC3839618 .

Rosenblum A, Joseph H, Fong, C, Kipnis S, Cleland CM, Portenoy RK (2003).
Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities
Journal of the American Medical Association, 289 (18), 2370-2378. doi: 10.1001/jama.289.18.2370.

Dr. Cleland's Research Gate Profile
Selected Press